Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates

BMC Microbiology

Volumn 11, Issue , 2011, Pages

  Junqueira, Juliana C ^a   Fuchs, Beth B ^b   Muhammed, Maged ^b   Coleman, Jeffrey J ^b   Suleiman, Jamal Mah ^c   Vilela, Simone Fg ^a   Costa, Anna Cbp ^a   Rasteiro, Vanessa Mc ^a   Jorge, Antonio Oc ^a   Mylonakis, Eleftherios ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ACRYLIC ACID RESIN; SILICONE DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BIOFILM; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA NORVEGENSIS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLAVISPORA LUSITANIAE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUNGAL STRAIN; FUNGUS ISOLATION; GALLERIA MELLONELLA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INVERTEBRATE; KLUYVEROMYCES MARXIANUS; MALE; MINIMUM INHIBITORY CONCENTRATION; MUCOCUTANEOUS CANDIDIASIS; NONHUMAN; PATHOGENICITY; AGED; ANIMAL; COMPARATIVE STUDY; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; LEPIDOPTERA; MICROBIOLOGY; MIDDLE AGED; SALIVA; THRUSH; VIRULENCE;

ANIMALIA; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; GALLERIA; GALLERIA MELLONELLA;

ACRYLIC RESINS; ADULT; AGED; ANIMALS; BIOFILMS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; FEMALE; HIV INFECTIONS; HUMANS; LEPIDOPTERA; MALE; MIDDLE AGED; SALIVA; SILICONES; VIRULENCE;

EID: 80155123527     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-11-247     Document Type: Article

References (43)

1. Antifungal photodynamic therapy. Donnely RF, McCarron PA, Tunney MM, Microbiological Research 2008 163 1 12 10.1016/j.micres.2007.08.001 18037279 (Pubitemid 350251183)
2. Candida infection and colonization in critically ill surgical patients. Johnson DW, Cobb JP, Virulence 2010 1 355 356 10.4161/viru.1.5.13254 21178469
3. Candida infection and colonization among non-trauma emergency surgery patients. Kourkoumpetis T, Manolakaki D, lmahos G, Chang Y, Alam HB, De Moya MM, Sailhamer EA, Mylonakis E, Virulence 2010 1 359 366 10.4161/viru.1.5.12795 21178471
4. Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV infected patients with primary and recurrent oropharyngeal candidiasis. Hamza OJM, Matee MI, Moshi MJ, Simon EN, Mugusi F, Mikx FH, Heldermana WH, Rijs AJ, van der Ven AJ, Verweij PE, BMC Microbiology 2008 8 135 10.1186/1471-2180-8-135 18694525
5. In vitro biofilm activity of non-Candida albicans Candida species. Silva S, Henriques M, Oliveira R, Williams D, Azeredo J, Current Microbiology 2010 61 534 540 10.1007/s00284-010-9649-7 20401483
6. Silicone colonization by non-Candida albicans Candida species in the presence of urine. Silva S, Negri M, Henriques M, Oliveira R, Williams D, Azeredo J, Journal of Medical Microbiology 2010 59 747 754 10.1099/jmm.0.017517- 0 20299506
7. Adhesive properties and hydrolytic enzymes of oral Candida albicans strains. Noumi E, Snoussi M, Hentati H, Mahdouani K, del Castillo L, Valentin E, Sentandreu R, Bakhrouf A, Mycopathologia 2010 169 269 278 10.1007/s11046-009- 9259-8 19946798
8. Function of Candida albicans adhesion Hwp1 in biofilm formation. Nobile CJ, Nett JE, Andes DR, Mitchell AP, Eukaryotic Cell 2006 5 1604 1610 10.1128/EC.00194-06 17030992 (Pubitemid 44622591)
9. Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata biofilms. Seneviratne CJ, Silva WJ, Jin LJ, Samaranayake YH, Samaranayake LP, Archives of Oral Biology 2009 54 1052 1060 10.1016/j.archoralbio.2009.08.002 19712926
10. Role of mini-host models in the study of medically important fungi. Chamilos G, Lionakis MS, Lewis RE, Kontoyiannis DP, Lancet Infectious Diseases 2007 7 42 55 10.1016/S1473-3099(06)70686-7 17182343 (Pubitemid 44917781)
11. Worms and flies as genetically tractable animal models to study host-pathogen interactions. Mylonakis E, Aballay A, Infection and Immunity 2005 73 3833 3841 10.1128/IAI.73.7.3833-3841.2005 15972468 (Pubitemid 40923120)
12. Using non-mammalian hosts to study fungal virulence and host defense. Fuchs BB, Mylonakis E, Current Opinion in Microbiology 2006 9 346 351 10.1016/j.mib.2006.06.004 16814595 (Pubitemid 44108716)
13. Galleria mellonella and the study of fungal pathogenesis: making the case for another genetically tractable model host. Mylonakis E, Mycopathologia 2008 165 1 3 10.1007/s11046-007-9082-z 18060516
14. Pre-expose of yeast protects larvae of Galleria mellonella from a subsequent lethal infection by Candida albicans and is mediated by the increased expression of antimicrobial peptides. Bergin D, Murphy L, Keenan J, Clynes M, Kavanagh K, Microbes and Infection 2006 8 2105 2112 10.1016/j.micinf.2006.03.005 16782387 (Pubitemid 44311574)
15. 3]. Rowan R, Moran C, McCann M, Kavanagh K, Biometals 2009 22 461 467 10.1007/s10534-008-9182-3 19082779
16. Effect of pre-incubation temperature on susceptibility of Galleria mellonella larvae to infection by Candida albicans. Mowlds P, Kavanagh K, Mycopathologia 2008 165 5 12 10.1007/s11046-007-9069-9 17922218 (Pubitemid 351153279)
17. Role of filamentation in Galleria mellonella killing by Candida albicans. Fuchs BB, Eby J, Nobile CJ, El Khoury JB, Mitchell AP, Mylonakis E, Microbes and Infection 2010 12 488 496 10.1016/j.micinf.2010.03.001 20223293
18. Candida albicans IRS4 contributes to hyphal formation and virulence after the initial stages of disseminated candidiasis. Badrane H, Cheng S, Nguyen MH, Jia HY, Zhang Z, Weisner N, Clancy CJ, Microbiology 2005 151 2923 2931 10.1099/mic.0.27998-0 16151204 (Pubitemid 41309565)
19. Differences in exoenzyme production and adherence ability of Candida spp. isolates from catheter, blood and oral cavity. Costa CR, Pastos XS, Souza LKH, Lucena PA, Fernandes OFL, Silva MRR, Revista do Instituto de Medicina Tropical de São Paulo 2010 52 139 143 10.1590/S0036-46652010000300005
20. Biofilm formation in clinical Candida isolates and its association with virulence. Hasan F, Xess I, Wang X, Jain N, Fries BC, Microbes and Infection 2009 11 753 761 10.1016/j.micinf.2009.04.018 19409507
21. Comparison of standard phenotypic assays with a PCR method to discriminate Candida albicans and Candida dubliniensis. MähB B, Stehr F, Sichafer W, Neuber V, Mycoses 2005 58 55 61 (Pubitemid 40255403)
22. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard M27-A2. CLSO, Wayne, PA, USA 2002
23. Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Nobile CJ, Mitchell AP, Current Microbiology 2005 15 1150 1155 (Pubitemid 40841360)
24. Antifungal chemical compounds identified using a C. elegans pathogenicity assay. Breger J, Fuchs BB, Aperis G, Moy TI, Ausubel FM, Mylonakis E, PLoS Pathogens 2007 3 168 178 10.1371/journal.ppat.0030168 (Pubitemid 350291600)
25. Development of an insect model for the in vivo pathogenicity testing of yeasts. Cotter G, Doyle S, Kavanagh K, FEMS Immunology and Medical Microbiology 2000 27 163 169 10.1111/j.1574-695X.2000.tb01427.x 10640612 (Pubitemid 30047095)
26. Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae. Brennan M, Thomas DY, Whiteway M, Kavanagh K, FEMS Immunology and Medical Microbiology 2002 34 153 157 10.1111/j.1574-695X.2002. tb00617.x 12381467
27. Methods for using Galleria mellonella as a model host to study fungal pathogenesis. Fuchs BB, O'Brien E, El Khoury JB, Mylonakis E, Virulence 2010 1 475 482 10.4161/viru.1.6.12985 21178491
28. Infection-related gene expression in Candida albicans. Brown AJP, Odds FC, Gow NAR, Current Opinion in Microbiology 2007 10 307 313 10.1016/j.mib.2007.04.001 17707687 (Pubitemid 47404944)
29. Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars. Jin Y, Samaranayake LP, Samaranayake Y, Yip HK, Archives of Oral Biology 2004 49 789 798 10.1016/j.archoralbio.2004.04.011 15308423 (Pubitemid 39081809)
30. Community lifestyle of Candida in mixed biofilms: a mini review. Thein ZM, Seneviratne CJ, Samaranayake YH, Samaranayake LP, Mycoses 2009 52 467 475 10.1111/j.1439-0507.2009.01719.x 19486299
31. Candida biofilms and oral candidosis: treatment and prevention. Willians DW, Kuriyama T, Silva S, Malic S, Lewis MAO, Periodontology 2000 2011 55 250 265 10.1111/j.1600-0757.2009.00338.x 21134239
32. Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans. Peleg AY, Tampakakis E, Fuchs BB, Eliopouls GM, Moellering RC, Mylonakis E, Proceedings of the Nationall Academy of Sciences USA 2008 105 14585 14590 10.1073/pnas.0805048105
33. Improvement of XTT assay performance for studies involving Candida albicans biofilm. Silva WJ, Seneviratne J, Parahitiyawa N, Rosa EAR, Samaranayake LP, Del Bel Crury AA, Brazilian Dental Journal 2008 19 364 369 19180329
34. Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Cowen L, Singh SD, Köhler JR, Collins C, Zaas AK, Schell WA, Aziz H, Mylonakis E, Perfect JR, Whitesell L, Lindquist S, Proceedings of the Nationall Academy of Sciences 2009 106 2818 2823 10.1073/pnas.0813394106
35. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Mylonakis E, Moreno R, El Khoury JB, Idnurm A, Heitman J, Calderwood SB, Ausubel FM, Diener A, Infection and Immunity 2005 73 3842 3850 10.1128/IAI.73.7.3842-3850.2005 15972469 (Pubitemid 40923121)
36. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. Krcmery V, Barnes AJ, Journal of Hospital Infection 2002 50 243 260 10.1053/jhin.2001.1151 12014897 (Pubitemid 37554852)
37. Emerging opportunistic yeast infections. Miceli MH, Díaz JA, Lee SA, The Lancet Infectious Diseases 2011 11 42 151
38. Comparasion of the epidemiology, drug resistance mechanisms and virulence of Candida dublinienses and Candida albicans. Sullivan DJ, Moran GP, Pinjon E, Al-Mosaid A, Stokes C, Vaughan C, Coleman DC, FEMS Yeast Research 2004 4 369 376 10.1016/S1567-1356(03)00240-X 14734017 (Pubitemid 38156201)
39. Molecular fingerprinting methods for the discrimination between C. albicans and C. dubliniensis. Neppelenbroek KH, Campanha NH, Spolidorio DMP, Spolidorio LC, Séo RS, Pavarina AC, Oral Diseases 2006 12 242 253 10.1111/j.1601-0825.2005.01189.x 16700733 (Pubitemid 43736413)
40. Differential virulence of Candida albicans and Candida dubliniensis: A role for Tor1 Kinase? Sullivan D, Moran GP, Virulence 2011 2 77 81 10.4161/viru.2.1.15002 21289475
41. Pathogenicity and virulence of Candida dubliniensis: comparison with C. albicans. Vilela MM, Kamei K, Sano A, Tanaka R, Uno J, Takahashi I, Ito J, Yarita K, Miyaji M, Medical Mycology 2002 40 249 257 12146754 (Pubitemid 34752323)
42. Variation of cell surface hydrophobicity and biofilm formation among genotypes of Candida albicans and Candida dubliniensis under antifungal treatment. Borecká-Melkusová S, Bujdáková H, Canadian Journal of Microbiology 2008 54 718 724 10.1139/W08-060 18772934
43. Experimental systemic virulence of oral Candida dubliniensis isolates in comparison with Candida albicans, Candida tropicalis and Candida krusei. Koga-Ito CY, Komiyama EY, Martins CAP, Vasconcellos TC, Jorge AOC, Carvalho YR, Prado RF, Balducci I, Mycoses 2011 19 278 85